abstract |
Compounds of formula (I) (see formula (I)): and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the enzyme IGF-1 R and are useful for treatment and / or the prevention of various diseases and conditions that respond to treatment by the inhibition of tyrosine kinases. |